Creganna Medical Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Creganna Medical Group - overview
Established
1980
Location
Galway, -, Ireland
Primary Industry
Medical Devices & Equipment
About
Creganna-Tactx Medical specializes in the development and manufacturing of advanced medical devices focused on minimally invasive healthcare solutions, enhancing surgical efficiency and patient recovery. Founded by Ian Quinn in 1980 in Galway, Ireland, Creganna-Tactx Medical develops medical devices, including access and delivery systems. In February 2016, TE Connectivity Ltd agreed to acquire Creganna Medical Group from Permira and Altaris for USD 895 million. The deal was completed in April 2016.
Creganna-Tactx Medical specializes in the development and manufacturing of advanced medical devices, focusing on minimally invasive healthcare solutions. Their product offerings include access and delivery devices such as metal shafts, wire and coil systems, braid shafts, medical balloons, custom extrusion molding, mold technology, and specialized needles. These products are designed to improve patient outcomes and are supplied to hospitals, surgical centers, and medical device companies across North America, Europe, and Asia-Pacific. Creganna-Tactx Medical generates revenue through business-to-business transactions with healthcare providers and medical device manufacturers, selling high-quality components directly to hospitals and surgical centers.
The company collaborates with other medical device firms to integrate their products into larger medical systems, aligning pricing strategies with industry standards. Creganna-Tactx Medical aims to expand its product line and enter new geographic markets. Leveraging the recent acquisition funding, the company plans to introduce new innovative medical devices targeted for launch by the end of 2024. They are also focusing on expanding into Asia-Pacific and Latin America by 2025 to meet the growing demand for minimally invasive surgical solutions.
Current Investors
Altaris
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Biomaterials
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Creganna Medical Group - financials
| Fiscal Year Ended | Jul 31, 2012 | Jul 31, 2013 | Jul 31, 2014 | Jul 31, 2015 | Jul 31, 2016 | Jul 31, 2017 | Jul 31, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - |
| NET Income (USD) | - | - | - | - | - | - | - |
| % Net Margin | - | - | - | - | - | - | - |
Creganna Medical Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Creganna Medical Group | - | ||||||||
| Add-on, Trade Sale | Completed | Precision Wire Components | - | ||||||||
| Add-on | Completed | ABT Medical | - | ||||||||
| Secondary Buyout | Completed | Creganna Medical Group | - | ||||||||
| Add-on | Completed | Tactx Medical | - |
Displaying 1 - 5 of 6
Creganna Medical Group - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.